Showing results (651-660 of 708) with videos related to
Sort By:
Pageof 71
JACC. Advances|June 18, 2026
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort StudySabin Filimon, Azin Ghamari, Azin Vakilpour, et al.Plos Neglected Tropical Diseases|December 18, 2018
NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous systemCaitlin D French, Rodney E Willoughby, Amy Pan, et al.The Journal of Allergy and Clinical Immunology|September 28, 2016
Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skinHitokazu Esaki, Patrick M Brunner, Yael Renert-Yuval, et al.Molecular Neurodegeneration|October 15, 2025
Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapiesEmily L Ward, Larry Benowitz, Thomas M Brunner, et al.Blood Cancer Journal|November 1, 2024
Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimenShai Shimony, Hari S Raman, Yael Flamand, et al.Blood Advances|June 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMMLAndrew M Brunner, Yiwen Liu, Jacqueline S Garcia, et al.British Journal of Haematology|July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remissionAndrew M Brunner, Shuli Li, Amir T Fathi, et al.Blood Advances|September 23, 2022
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignanciesAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.JAMA Oncology|December 17, 2020
Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical TrialAreej El-Jawahri, Thomas W LeBlanc, Alison Kavanaugh, et al.Haematologica|August 5, 2021
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative studySabine Kayser, Michael Kramer, David Martínez-Cuadrón, et al.Pageof 71